Celgene Corporation and Acceleron Pharma, Inc developing novel therapeutics

Celgene Corporation and Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced the initiation of a Phase 2 clinical study of its lead compound ACE-011 in patients with multiple myeloma. ACE-011 is being developed to treat bone loss associated with multiple myeloma and [...]

National Breast Cancer Awareness Month Shines Spotlight on Oral Mucositis

As millions of Americans participate in educational initiatives as part of National Breast Cancer Awareness Month, they should keep in mind an important yet under-recognized consequence of breast cancer therapy: oral mucositis, one of the most common and debilitating side effects of cancer treatment.
Oral mucositis (OM) is a painful inflammation/ulceration of the mucous membranes in [...]

Cell Therapeutics, Inc. announced to request a hearing with the NASDAQ Listing Qualifications Panel to present a plan for regaining compliance with NASDAQ Marketplace Rule

Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the Company intends to request a hearing with the NASDAQ Listing Qualifications Panel to present a plan for regaining compliance with NASDAQ Marketplace Rule 4450(b)(1)(A), which requires a minimum market value of listed securities of $50 million. CTI received a Staff Determination Letter from [...]

Vical Incorporated is presenting expanded clinical dat

Vical Incorporated today is presenting expanded clinical data and new nonclinical data demonstrating that the company’s Vaxfectin® adjuvant may be broadly applicable in DNA- and protein-based infectious disease vaccines and peptide-based cancer vaccines. Alain P. Rolland, Pharm.D., Ph.D., Vical’s Senior Vice President of Product Development, will present the data today, Wednesday, October 8, at the [...]

Apieron, Inc. Announces Appointment of Holly McGarraugh as President and Chief Executive Officer

Apieron, Inc. (www.apieron.com) announced today that its Board of Directors has appointed Holly McGarraugh as president and CEO of the company, effective immediately. Ms. McGarraugh replaces Rich Lotti, who resigned to pursue other business interests.
“We chose Holly for the CEO position because of her strong commercialization experience,” said Wende Hutton, Apieron Board member and partner [...]

Omeros and BlueCrest Announce $20 Million Debt Facility

Omeros Corporation, a Seattle-based biopharmaceutical company, today announced the establishment of a $20 million debt facility with BlueCrest Capital Finance. The facility consists of a $5 million term loan drawn by Omeros at closing and the right, subject to certain conditions, to access up to the remaining $15 million. Other terms were not disclosed.
“This credit [...]

Cadient Group’s GEL Interactive Technologies Launches OneVoice: KOL Platform

GEL Interactive Technologies, a Cadient Group company, announced today the launch of its Key Opinion Leader (KOL) management platform, OneVoice: KOL. OneVoice: KOL provides the critical features and tools needed to help brand teams and their partners manage an active advocate campaign throughout the brand lifecycle – from advocate identification through the management and development [...]

Retacrit(R) Demonstrates Efficacy And Safety In Chemotherapy-Induced Anaemia

The world leader in generic injectable pharmaceuticals, presented new data showing Retacrit® (epoetin zeta) is an effective treatment for chemotherapy-induced anaemia,1 with an acceptable safety and tolerability profile.2 Results from the Phase III trial were presented at the European Society for Medical Oncology (ESMO) congress.
Retacrit is a biosimilar erythropoietin approved in Europe3 for subcutaneous administration [...]

The surgery manager software maintains workflow data so doctors can focus on the patient.

GE Healthcare announced today that the company will install its Centricity® Perioperative Manger and Anesthesia products in hospitals and clinics affiliated with Connecticut-based Yale New Haven Hospital (YNHH), and the two organizations will team to develop new enhancements to GE’s perioperative products.
GE’s Centricity Perioperative’s clinical information system integrates data across the surgical process, from the [...]